NEW YORK (GenomeWeb) – MDxHealth announced today that it has received a positive coverage determination from Independence Blue Cross for its ConfirmMDx for Prostate Cancer test.

Independence, a member of the Blue Cross Blue Shield Association (BCBSA), provides insurance coverage for patients in 32 states and Washington, DC. The company's coverage decision marks the first time a BCBSA plan has approved coverage for ConfirmMDx, MDxHealth said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.